Antidiabetic effect of Salvia verticillata L. aerial parts in normal and streptozotocin-induced diabetic rats

International Journal of Pharmacology

Volumn 7, Issue 1, 2011, Pages 66-73

  Eidi, A ^a   Eidi, M ^b   Shahmohammadi, P ^a   Mozaffarian, V ^c   Rustaiyan, A ^a   Mazooji, A ^b  

^a ISLAMIC AZAD UNIVERSITY   (Iran)

^b ISLAMIC AZAD UNIVERSITY   (Iran)

^c RESEARCH INSTITUTE OF FORESTS AND RANGELANDS   (Iran)

Author keywords

Hypoglycemic; Hypolipidemic; Salvia verticillata l.; Streptozotocin

Indexed keywords

ALANINE AMINOTRANSFERASE; ALCOHOL; ANTIDIABETIC AGENT; ASPARTATE AMINOTRANSFERASE; CHOLESTEROL; CREATININE; GLIBENCLAMIDE; GLUCOSE; INSULIN; PLANT EXTRACT; SALVIA VERTICILLATA EXTRACT; STREPTOZOCIN; TRIACYLGLYCEROL; UNCLASSIFIED DRUG; UREA; URIC ACID;

ALANINE AMINOTRANSFERASE BLOOD LEVEL; ANIMAL EXPERIMENT; ANIMAL MODEL; ARTICLE; ASPARTATE AMINOTRANSFERASE BLOOD LEVEL; CHOLESTEROL BLOOD LEVEL; CONTROLLED STUDY; CREATININE BLOOD LEVEL; DIABETES MELLITUS; DRUG DOSE COMPARISON; GLUCOSE BLOOD LEVEL; INSULIN BLOOD LEVEL; MALE; MEDICINAL PLANT; NONHUMAN; RAT; SALVIA VERTICILLATA; SOLVENT EXTRACTION; STREPTOZOCIN DIABETES; TRIACYLGLYCEROL BLOOD LEVEL; UREA BLOOD LEVEL; URIC ACID BLOOD LEVEL; WEIGHT REDUCTION;

EID: 78649375723     PISSN: 18117775     EISSN: 18125700     Source Type: Journal    
DOI: 10.3923/ijp.2011.66.73     Document Type: Article

References (38)

1. Akah, P.A. and C.I. Okafor, 1992. Blood sugar lowering effect of Vernonia amygdalina Del, in an experimentalrabbitmodel. Phytother. Res., 6: 171-173.
2. Barham, D. and P. Trinder, 1972. An improved color reagent for the determination of blood glucose by the oxidase system. Analyst, 97: 142-145.
3. Baricevic, D. and T. Bartol, 2001. The Biological/Pharmacological Activity of the Salvia genus Pharmacology. In: The Genus Salvia, Kintzios, S.E. (Ed.). Harwood Academic Publishers, Abingdon, Marston.
4. Capasso, R., A.I. Izzo, F. Capasso, G. Romussi, A. Bisio and N. Mascolo, 2004. A diterpenoid from Salvia cinnabarina inhibits mouse intestinal motility in vivo. Planta Med., 70: 375-377.
5. Chalchat, J.C., A. Michet and B. Pasquier, 1998. Study of clones of Salvia officinalis L. yields and chemical composition of essential oil. Flavour Fragr. J., 13: 68-70.
6. Cuvelier, M.E., H. Berset and H. Richard, 1994. Antioxidant constituents in sage (Salvia officinalis). J. Agric. Food Chem., 42: 665-669.
7. Day, C, 1998. Traditional plant treatments for diabetes mellitus: Pharmaceutical foods. Br. J. Nutr., 80: 5-6.
8. El-Fiky, F.K., M.A. Abou-Karam and E.A. Afify, 1996. Effect oîLuffa aegyptiaca (seeds) and Carissa edulis (leaves) extracts on blood glucose level of normal and streptozotocin diabetic rats. J. Ethnopharm., 50: 43-47.
9. Fossati, P., L. Prencipe and G. Berti, 1980. Use of 3,5- dichloro-2-hydroxybenzenesulfonic acid/4-aminophenazone chromogenic system in direct enzymic assay of uric acid in serum and urine. Clin. Chem., 26: 227-231.
10. Gray, A.M., Y.H.A. Abdel-Wahab and P.R. Flatt, 2000. The traditional plant treatment, Sambucus nigra (elder), exhibits insulin-like and insulin-releasing actions in vitro. J. Nutr., 130: 15-20.
11. Grover, J.K., V. Vats and S.S. Rathi, 2000. Anti- hyperglycemic effect of Eugenia jambolona and Tinospora cordifolia in experimental diabetes and their effects on key metabolic enzymes involved in carbohydrate metabolism. J. Ethnopharmacol., 73: 461-470.
12. Krstic, L., D. Malencic and G. Anackov, 2006. Structural investigations of trichomes and essential oil composition of Salvia verticillata. Bot. Helv., 116: 159-168.
13. Leahy, J.L., 2005. Pathogenesis of type 2 diabetes mellitus. Arch. Med. Res., 36: 197-209.
14. Li, W.L., H.C. Zheng, J. Bukuru and N. de Kimpe, 2004. Natural medicines used in the traditional Chinese medical system for therapy of diabetes mellitus. J. Ethnopharmacol., 92: 1-21.
15. Lima, CF., P.B. Andrade, R.M. Seabra, M. Fernandes-Ferreira and C. Pereira-Wilson, 2005. The drinking of a Salvia officinalis infusion improves liver antioxidant status in mice and rats. J. Ethnopharmacol., 97: 383-389.
16. Luo, Q., Y.C.J. Yan, M. Sun and H. Corkeb, 2004. Hypoglycemic and hypolipidemic effects and antioxidant activity of fruit extracts from Lycium barbarum. Life Sei., 76: 137-149.
17. Maiti, R., U.K. Das and D. Ghosh, 2005. Attenuation of hyperglycaemia and hyperlipidemia in streptozotocin induced diabetic rats by aqueous extract of seed of Tamarindus indica. Biol. Pharm. Bull., 28: 1172-1176.
18. Maries, R.J. and N.R. Farnsworth, 1995. Antidiabetic plants and their active constituents. Phytomedicine, 2: 137-139.
19. McCarty, P. and P. Zimmet, 1997. Diabetes 1994-2010: Global estimate and projections. Diabetes Care, 20: 1785-1790.
20. Moss, D.W. and A.R. Handerson, 1999. Clinical Enzymology. In: Tiets Texbook of Clinical Chemistry, Burtis, C.A. and E.R. Ashwood (Eds.). 3rd Edn, W.B. Saunders, Philadelphia, pp: 617-721.
21. Nagy, G., G. Günther, I. Mathe, G. Blunden, M. Yang and T.A. Crabb, 1999. Diterpenoids from Salvia glutibnosa, S. austrica, S. tomentosa and S. verticillata roots. Phytochemistry, 52: 1105-1109.
22. Navarro, CM., P.M. Montilla, A. Martin, J. Jimenez and P.M. Utrilla, 1993. Free radicals scavenger and antihepatotoxic activity of rosmarinus. Plant Med., 59: 312-314.
23. Oladele, S.B., J.O. Ayo and A.O. Adaudi, 1995. Medicinal and physiological properties of flavonoids, coumarin derivatives and anthraquinones of plant origin. W. Afr. J. Pharmacol. Drug Res., 11: 134-144.
24. Ramesh, B. and K.V. Pugalendi, 2006. Impact of umbelliferone (7-hydroxycoumarin) on hepatic marker enzymes in streptozotocin diabetic rats. Ind. J. Pharmacol, 38: 209-210.
25. Ren, Y., P.J. Houghton, R.C. Hider and M.J.R. Howes, 2004. Novel diterpenoid acetylcholinesterase inhibitors from Salvia miltiorhiz. Planta Med., 70: 201-204.
26. Rifai, N., P.S. Bachonk and J.J. Albers, 1999. Lipids, Lipoproteins and Apolipoproteins. In: Tietz Textbook of Clinical Chemistry, Burtis, C.A. and E.R. Ashwood (Eds.). 3rd Edn., W.B. Saunders Company, Philadelphia, pp: 809-861.
27. Sharma, S.B., A. Nasir, K.M. Prabhu, P.S. Murthy and G. Dev, 2003. Hypoglycaemic and hypolipidemic effect of ethanolic extract of seeds of Eugenia jambolana in alloxan-induced diabetic rabbits. J. Ethanopharmacol., 85: 201-206.
28. Shmde, U.A. and R.K. Goyal, 2003. Effect of chromium picolinate on histopathological alterations in STZ and neonatal STZ diabetic rats. J. Cell. Mol. Med., 7: 322-329.
29. Sonmez, U, G. Topcuand A. Ulubelen, 1997. Constituents of Salvia verticillata. Turk. J. Chem., 21: 376-382.
30. Tepe, B., O. Eminaaolu, H.A. Akpulat, E. Ve-Aydin, 2006. Antioxidant potentials and rosmarinic acid levels of the methanolic extracts of Salvia verticillata (L.) subsp. verticillata and Salvia verticillata (L.) subsp.amasiaca (Freyn and Bornm) Bornm. Food Chem., 98: 1-18.
31. Thomas, L., 1998. Clinical Laboratory Diagnostics. 1st Edn., TH-Books Verlagsgesellschaft, Frankfurt, Germany, pp: 208-214.
32. Umesh, CS., K. Yadav, K. Moorthy and Z.B. Najma, 2005. Combined treatment of sodium orthovanadate and Mormodica charantia fruit extract prevents alterations in lipid profile and lipogenic enzymes an alloxan diabetic rats. Mol. Cell. Biochem., 268: 111-120.
33. WHO, 1980. The WHO Expert Committee on Diabetes Mellitus. World Health Organization, Geneva.
34. Watkins, P.J., 2003. ABC of diabetes, cardiovascular disease, hypertension and lipids. Br. Med. J., 326: 874-876.
35. Whitehead, M.W., N.D. Hawkes, I. Hainsworth and J.G.C. Kingham, 1999. A prospective study of the causes of notably raised aspartate transaminase of liver origin. Gut, 45: 129-133.
36. Yoon, J.C., P. Puigserver, G. Chen, J. Donovan and Z. Wu et al, 2001. Control of hepatic gluconeogenesis through the transcriptional coactivator PGC-1. Nature, 413: 131-138.
37. Zheng, Q.S., X.L. Sun, G.X. Li, M. Song and C.H. Wang, 2004. Protective effects of luteolin-7-glucoside against liver injury caused by carbon tetrachloride in rats. Pharmazie, 59: 286-289.
38. Zupko, I., J. Hohmann, D. Redei, G. Falkay, G. Janiesak and I. Mathe, 2001. Antioxidant activity of leaves of Salvia species in enzyme-dependent and enzyme-independent systems of lipid peroxidation and their phenolic constituents. Planta Med., 67: 366-368.